Cargando…
Six‐gene Assay as a new biomarker in the blood of patients with colorectal cancer: establishment and clinical validation
Colorectal cancer (CRC) is the second most common cancer in men and the third most common cancer in women. Although long‐term survival has improved over the past 30 years, at least 50% of patients with CRC will develop metastases after diagnosis. In this study, we examined whether quantifying the mR...
Autores principales: | Shou, Xin, Li, Yong, Hu, Weilei, Ye, Tingting, Wang, Guosheng, Xu, Feng, Sui, Meihua, Xu, Yibing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441906/ https://www.ncbi.nlm.nih.gov/pubmed/30556647 http://dx.doi.org/10.1002/1878-0261.12427 |
Ejemplares similares
-
Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
por: Hu, Weilei, et al.
Publicado: (2019) -
Cocktail Strategy Based on NK Cell-Derived Exosomes and Their Biomimetic Nanoparticles for Dual Tumor Therapy
por: Wang, Guosheng, et al.
Publicado: (2019) -
Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
por: Wu, Miaowei, et al.
Publicado: (2020) -
Establishment and characterisation of six human colorectal adenocarcinoma cell lines.
por: Kirkland, S. C., et al.
Publicado: (1986) -
Establishment and validation of a clinicopathological prognosis model of gastroenteropancreatic neuroendocrine carcinomas
por: Chen, Jing, et al.
Publicado: (2022)